<?xml version='1.0' encoding='UTF-8'?>
<rss xmlns:arxiv="http://arxiv.org/schemas/atom" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" version="2.0">
  <channel>
    <title>q-bio.TO updates on arXiv.org</title>
    <link>http://rss.arxiv.org/rss/q-bio.TO</link>
    <description>q-bio.TO updates on the arXiv.org e-print archive.</description>
    <atom:link href="http://rss.arxiv.org/rss/q-bio.TO" rel="self" type="application/rss+xml"/>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <language>en-us</language>
    <lastBuildDate>Thu, 27 Feb 2025 05:00:44 +0000</lastBuildDate>
    <managingEditor>rss-help@arxiv.org</managingEditor>
    <pubDate>Thu, 27 Feb 2025 00:00:00 -0500</pubDate>
    <skipDays>
      <day>Saturday</day>
      <day>Sunday</day>
    </skipDays>
    <item>
      <title>Validating the predictions of mathematical models describing tumor growth and treatment response</title>
      <link>https://arxiv.org/abs/2502.19333</link>
      <description>arXiv:2502.19333v1 Announce Type: new 
Abstract: Despite advances in methods to interrogate tumor biology, the observational and population-based approach of classical cancer research and clinical oncology does not enable anticipation of tumor outcomes to hasten the discovery of cancer mechanisms and personalize disease management. To address these limitations, individualized cancer forecasts have been shown to predict tumor growth and therapeutic response, inform treatment optimization, and guide experimental efforts. These predictions are obtained via computer simulations of mathematical models that are constrained with data from a patient's cancer and experiments. This book chapter addresses the validation of these mathematical models to forecast tumor growth and treatment response. We start with an overview of mathematical modeling frameworks, model selection techniques, and fundamental metrics. We then describe the usual strategies employed to validate cancer forecasts in preclinical and clinical scenarios. Finally, we discuss existing barriers in validating these predictions along with potential strategies to address them.</description>
      <guid isPermaLink="false">oai:arXiv.org:2502.19333v1</guid>
      <category>q-bio.TO</category>
      <category>cs.CE</category>
      <category>q-bio.CB</category>
      <category>q-bio.QM</category>
      <pubDate>Thu, 27 Feb 2025 00:00:00 -0500</pubDate>
      <arxiv:announce_type>new</arxiv:announce_type>
      <dc:rights>http://creativecommons.org/licenses/by-nc-nd/4.0/</dc:rights>
      <dc:creator>Guillermo Lorenzo, David A. Hormuth II, Chengyue Wu, Graham Pash, Anirban Chaudhuri, Ernesto A. B. F. Lima, Lois C. Okereke, Reshmi Patel, Karen Willcox, Thomas E. Yankeelov</dc:creator>
    </item>
    <item>
      <title>Computational modelling of bone growth and mineralization surrounding biodegradable Mg-based and permanent Ti implants</title>
      <link>https://arxiv.org/abs/2408.03820</link>
      <description>arXiv:2408.03820v2 Announce Type: replace-cross 
Abstract: In silico testing of implant materials is a research area of high interest, as cost- and labour-intensive experiments may be omitted. However, assessing the tissue-material interaction mathematically and computationally can be very complex, in particular when functional, such as biodegradable, implant materials are investigated. In this work, we expand and refine suitable existing mathematical models of bone growth and magnesium-based implant degradation based on ordinary differential equations. We show that we can simulate the implant degradation, as well as the osseointegration in terms of relative bone volume fraction and changes in bone ultrastructure when applying the model to experimental data from titanium and magnesium-gadolinium implants for healing times up to 32 weeks. An additional sensitivity analysis highlights important parameters and their interactions. Moreover, we show that the model is predictive in terms of relative bone volume fraction with mean absolute errors below 6%.</description>
      <guid isPermaLink="false">oai:arXiv.org:2408.03820v2</guid>
      <category>q-bio.QM</category>
      <category>q-bio.TO</category>
      <pubDate>Thu, 27 Feb 2025 00:00:00 -0500</pubDate>
      <arxiv:announce_type>replace-cross</arxiv:announce_type>
      <dc:rights>http://creativecommons.org/licenses/by/4.0/</dc:rights>
      <dc:creator>Nik Pohl (Institute of Metallic Biomaterials, Helmholtz-Zentrum Hereon), Domenik Priebe (Institute of Metallic Biomaterials, Helmholtz-Zentrum Hereon), Tamadur AlBaraghtheh (Institute of Metallic Biomaterials, Helmholtz-Zentrum Hereon, Institute of Surface Science, Helmholtz-Zentrum Hereon), Sven Schimek (Institute of Metallic Biomaterials, Helmholtz-Zentrum Hereon), D. C. Florian Wieland (Institute of Metallic Biomaterials, Helmholtz-Zentrum Hereon), Diana Kr\"uger (Institute of Metallic Biomaterials, Helmholtz-Zentrum Hereon), Sascha Trostorff (Department of Mathematics, Faculty of Mathematics and Natural Sciences, Kiel University), Regine Willumeit-R\"omer (Institute of Metallic Biomaterials, Helmholtz-Zentrum Hereon, Kiel, Nano, Surface, and Interface Science - KiNSIS, Kiel University), Ralf K\"ohl (Department of Mathematics, Faculty of Mathematics and Natural Sciences, Kiel University, Kiel, Nano, Surface, and Interface Science - KiNSIS, Kiel University), Berit Zeller-Plumhoff (Institute of Metallic Biomaterials, Helmholtz-Zentrum Hereon, Kiel, Nano, Surface, and Interface Science - KiNSIS, Kiel University, Data-driven Analysis and Design of Materials, Faculty of Mechanical Engineering and Marine Technologies, University of Rostock, Department Life, Light &amp; Matter, University of Rostock)</dc:creator>
    </item>
  </channel>
</rss>
